Eksentricity

• Funding and Investors
  Crosby Health raises $2.2M in pre-seed funding led by Amplo Ventures, with participation from NOMO Ventures and angel investors.
• AI Revenue Cycle Expert
  The company’s AI, Apollo, specializes in denial management, revenue cycle optimization, and automating clinical appeals for healthcare providers.
• Use of Funds
  Funds will be used to expand development efforts and business reach for Crosby Health’s proprietary AI technology.

Impact

1. Enhanced Revenue Recovery
   Apollo’s capabilities in denial management and revenue cycle optimization improve financial outcomes for healthcare providers.
2. Streamlined Administrative Processes
   Automation of clinical appeals and medical coding reduces administrative burden, allowing healthcare staff to focus on patient care.
3. Increased Efficiency
   Advanced clinical language model improves tracking intelligence, leading to more efficient revenue cycle management.
4. Investment Appeal
   Strong investor interest underscores confidence in Crosby Health’s potential to revolutionize healthcare administration with AI.
5. Broader Market Reach
   Funding will facilitate expansion, allowing more healthcare providers to benefit from Apollo’s advanced AI capabilities.

Read more